Dr. Charisse Marie Orme, MD, PhD

Dr. Orme practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Orme's NPI, 1861767097, was assigned on March 21, 2012. Dr. Orme graduated from Yale School of Medicine in 2012. Dr. Orme holds California license 141036.

Dr. Orme's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Orme's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Orme is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Orme to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orme practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Orme's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Orme is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Orme's licenses on file in 2 states: California and New York.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, corns and calluses, hives, itchy rashes, minor injury on trunk and minor injury to a limb among the conditions Dr. Orme treats.

CMS data shows 4,164 Medicare services from Dr. Orme across 15 procedure codes in 2024, for 802 Medicare patients. Medicare paid $220,695 for them.

CMS counts 802 Medicare patients who saw Dr. Orme in 2024. The largest group is 75 to 84, with 339 patients. 71% of them have high cholesterol, and 60% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Orme's median patient age at 63, with 61% women.

In 2024, Dr. Orme wrote 1,342 Medicare Part D claims for 421 patients. 82% of them were for generic drugs. CMS names the drug for 1,223 of them, across 29 drugs with 11 or more claims each, at $1,008,189 in total drug cost. In 2023, CMS named 1,101 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Orme for performance year 2024, reported as part of a group. Dr. Orme accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orme as offering telehealth. CMS counts 1,192 procedures of removal of skin lesions by Dr. Orme, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Orme, published from 2011 to 2022. 2011 was the busiest year, with 3. The most frequent topics are Intracellular Signaling Peptides and Proteins, Skin and 3T3-L1 Cells. Dr. Orme has published most often in Dermatol Online J. Dr. Orme's most frequent co-authors are Dawn Zhang Eichenfield, MD, PhD, Brian Robert Hinds, MD and Richard J. Antaya, MD.

CMS Open Payments shows 2 general payments to Dr. Orme from 2 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $80.

Dr. Orme graduated from Yale School of Medicine in 2012.

Dr. Orme is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.